Analyst moves and MetLife Q1 income outlook

Equity research desks issued a series of rating and price target changes on April 7, 2026, affecting companies across financial services, technology, healthcare, industrials and real estate infrastructure. The moves highlight shifting views on valuation while, in many cases, leaving fundamental rating stances intact.

The updates included revised price targets from firms such as RBC, JPMorgan, Goldman Sachs, Scotiabank and Bernstein. Several of these changes were accompanied by reiterated recommendations, signaling analysts’ views on relative performance expectations for the affected stocks.

RBC raised its price target on CF Industries Holdings to $125, up from $100, while maintaining a Sector Perform rating. The change reflects RBC’s updated valuation outlook for the company within its sector coverage framework.

The reference to a Sector Perform rating indicates that RBC continues to see CF Industries as expected to perform in line with its sector peers, despite the higher price target. No additional commentary on underlying drivers was provided in the available summary.

JPMorgan adjusted its price target on Citigroup (C) to $131 from $134 and kept an Overweight rating on the stock. The Overweight stance signals that JPMorgan continues to expect Citigroup (C) shares to outperform the sector or broader coverage universe.

For Wells Fargo (WFC), JPMorgan reduced its price target to $91 from $99.50 and maintained a Neutral rating. The Neutral rating suggests an expectation that Wells Fargo (WFC)’s performance will be more in line with the market or sector benchmarks.

Goldman Sachs adjusted its price target on American Express (AXP) to $360 from $400 while maintaining a Buy rating. The Buy recommendation indicates that Goldman Sachs continues to see upside potential in the shares, notwithstanding the lower target level.

Goldman Sachs also revised its price target on ServiceNow to $188 from $216, again reiterating a Buy rating. The combination of a reduced target and a continued positive recommendation underscores Goldman Sachs’ view that the stock still offers attractive return potential relative to its coverage.

Scotiabank downgraded Equinix to Sector Perform from Sector Outperform and adjusted its price target to $1,050 from $997. The downgrade indicates a shift in Scotiabank’s relative performance expectations for the company.

Despite the lower rating, the higher price target suggests an updated valuation assessment at a new implied level, with Sector Perform signaling an expectation of performance broadly in line with sector peers.

Bernstein adjusted its price target on UnitedHealth Group (UNH) to $411 from $405 and maintained an Outperform rating. The Outperform stance reflects Bernstein’s view that UnitedHealth Group (UNH) is likely to deliver returns ahead of the broader market or sector.

The modest increase in target price indicates a slightly more positive valuation outlook while keeping the core investment thesis intact, as implied by the unchanged rating.

Separately, MetLife Inc disclosed in an SEC filing that it estimates first-quarter 2026 variable investment income of $475 million to $525 million on a pre-tax basis. The range provides investors with early guidance on a key earnings component.

The estimate focuses specifically on variable investment income, rather than total earnings, and offers a quantitative indication of expected contribution from this line item to MetLife’s Q1 2026 financial performance.